BetaPublic beta

Spending
Lobbying
Coming soon: Congress, Stocks

Spending
- Overview
- Agencies
- Programs
- Recipients
- Awards
Lobbying
Congress
Stocks

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Lobbying
Coming soon: Congress, Stocks

Overview Firms Clients Revolving Door Stands Out

NRX PHARMACEUTICALS — Lobbying — Receipts Report

LD-2 disclosure · Registration

NRX PHARMACEUTICALS

via THE VOGEL GROUP

3rd Quarter (July 1 - Sep 30) · 2021Posted Oct 20, 2021Filing document ↗LDA record ↗

Coverage · Registration filing — establishes the registrant/client relationship. No periodic income or expenses are reported at registration.

Client

Name: NRX PHARMACEUTICALS
Description: Pharmaceuticals
Location: Delaware · United States of America

Registrant

Firm: THE VOGEL GROUP
Description: Global lobbying and business advisory firm
Location: Washington, District of Columbia, United States of America

Lobbying activities

1 issue

Health Issues
Issues around EUAs (emergency use authorizations)
Lobbyistsmr ALEXANDER NICHOLAS VOGEL sr
Covered position (mr ALEXANDER NICHOLAS VOGEL sr): Former Chief Counsel, Senate Majority Leader Bill Frist

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.